These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9521600

  • 21. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK, Thomas DM.
    J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
    [Abstract] [Full Text] [Related]

  • 22. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD.
    J Exp Med; 1995 Jul 01; 182(1):75-85. PubMed ID: 7540658
    [Abstract] [Full Text] [Related]

  • 23. Brain-derived heat shock protein 70-peptide complexes induce NK cell-dependent tolerance to experimental autoimmune encephalomyelitis.
    Galazka G, Stasiolek M, Walczak A, Jurewicz A, Zylicz A, Brosnan CF, Raine CS, Selmaj KW.
    J Immunol; 2006 Feb 01; 176(3):1588-99. PubMed ID: 16424188
    [Abstract] [Full Text] [Related]

  • 24. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
    Bebo BF, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Sep 15; 45(6):680-9. PubMed ID: 8892079
    [Abstract] [Full Text] [Related]

  • 25. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.
    Int Immunol; 2004 Feb 15; 16(2):249-56. PubMed ID: 14734610
    [Abstract] [Full Text] [Related]

  • 26. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 15; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 27. Encephalitogenic T cells are present in Lewis rats protected from autoimmune encephalomyelitis by coimmunization with MBP73-84 and its analog.
    Stepaniak JA, Gould KE, Swanborg RH.
    J Neurosci Res; 1996 Aug 15; 45(4):447-54. PubMed ID: 8872905
    [Abstract] [Full Text] [Related]

  • 28. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD, Lemon M, Jones AJ, Vainiene M, Celnik B, Buenafe AC, Culbertson N, Bakke A, Vandenbark AA, Offner H.
    J Neurosci Res; 1996 Jan 01; 43(1):42-9. PubMed ID: 8838572
    [Abstract] [Full Text] [Related]

  • 29. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
    Buenafe AC, Vainiene M, Celnik B, Vandenbark AA, Offner H.
    J Immunol; 1995 Aug 01; 155(3):1556-64. PubMed ID: 7636217
    [Abstract] [Full Text] [Related]

  • 30. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
    Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB.
    Annu Rev Immunol; 2002 Aug 01; 20():101-23. PubMed ID: 11861599
    [Abstract] [Full Text] [Related]

  • 31. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM, Nicholson LB, Farzan M, Southwood S, Sette A, Sobel RA, Kuchroo VK.
    J Immunol; 1998 Oct 01; 161(7):3307-14. PubMed ID: 9759846
    [Abstract] [Full Text] [Related]

  • 32. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
    Ponomarev ED, Novikova M, Yassai M, Szczepanik M, Gorski J, Dittel BN.
    J Immunol; 2004 Aug 01; 173(3):1587-95. PubMed ID: 15265886
    [Abstract] [Full Text] [Related]

  • 33. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E, Belunis C, Bolin DR, Arceo R, Campbell R, Falcioni F, Vidović D, Hammer J, Nagy ZA.
    J Exp Med; 1996 Jun 01; 183(6):2635-44. PubMed ID: 8676084
    [Abstract] [Full Text] [Related]

  • 34. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
    Kuchroo VK, Sobel RA, Yamamura T, Greenfield E, Dorf ME, Lees MB.
    Pathobiology; 1991 Jun 01; 59(5):305-12. PubMed ID: 1716908
    [Abstract] [Full Text] [Related]

  • 35. Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis.
    Marín N, Eixarch H, Mansilla MJ, Rodríguez-Martín E, Mecha M, Guaza C, Álvarez-Cermeño JC, Montalban X, Villar LM, Espejo C.
    Clin Exp Immunol; 2014 Feb 01; 175(2):202-7. PubMed ID: 24188195
    [Abstract] [Full Text] [Related]

  • 36. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.
    Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK.
    Immunity; 1995 Oct 01; 3(4):397-405. PubMed ID: 7584131
    [Abstract] [Full Text] [Related]

  • 37. Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides.
    Sobel RA.
    J Neuroimmunol; 2000 Aug 01; 108(1-2):45-52. PubMed ID: 10900336
    [Abstract] [Full Text] [Related]

  • 38. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M, Takahashi I, Serada M, Koshio T, Nakagami K, Yuki Y, Kiyono H.
    J Autoimmun; 2001 Aug 01; 17(1):17-25. PubMed ID: 11488634
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK, Yu M, Yin L, Mathisen PM, Johnson JM, Kawczak JA.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):55-63. PubMed ID: 11063821
    [Abstract] [Full Text] [Related]

  • 40. Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing.
    Legge KL, Min B, Potter NT, Zaghouani H.
    J Exp Med; 1997 Mar 17; 185(6):1043-53. PubMed ID: 9091578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.